Feng Mingye, Chen James Y, Weissman-Tsukamoto Rachel, Volkmer Jens-Peter, Ho Po Yi, McKenna Kelly M, Cheshier Samuel, Zhang Michael, Guo Nan, Gip Phung, Mitra Siddhartha S, Weissman Irving L
Institute for Stem Cell Biology and Regenerative Medicine, Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford Cancer Institute, and.
Institute for Stem Cell Biology and Regenerative Medicine.
Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2145-50. doi: 10.1073/pnas.1424907112. Epub 2015 Feb 2.
Macrophage-mediated programmed cell removal (PrCR) is an important mechanism of eliminating diseased and damaged cells before programmed cell death. The induction of PrCR by eat-me signals on tumor cells is countered by don't-eat-me signals such as CD47, which binds macrophage signal-regulatory protein α to inhibit phagocytosis. Blockade of CD47 on tumor cells leads to phagocytosis by macrophages. Here we demonstrate that the activation of Toll-like receptor (TLR) signaling pathways in macrophages synergizes with blocking CD47 on tumor cells to enhance PrCR. Bruton's tyrosine kinase (Btk) mediates TLR signaling in macrophages. Calreticulin, previously shown to be an eat-me signal on cancer cells, is activated in macrophages for secretion and cell-surface exposure by TLR and Btk to target cancer cells for phagocytosis, even if the cancer cells themselves do not express calreticulin.
巨噬细胞介导的程序性细胞清除(PrCR)是在程序性细胞死亡之前清除病变和受损细胞的重要机制。肿瘤细胞上的“吃掉我”信号诱导PrCR,而诸如CD47等“别吃我”信号则会与之抗衡,CD47与巨噬细胞信号调节蛋白α结合以抑制吞噬作用。阻断肿瘤细胞上的CD47会导致巨噬细胞的吞噬作用。在这里,我们证明巨噬细胞中Toll样受体(TLR)信号通路的激活与阻断肿瘤细胞上的CD47协同作用,以增强PrCR。布鲁顿酪氨酸激酶(Btk)介导巨噬细胞中的TLR信号传导。钙网蛋白先前被证明是癌细胞上的“吃掉我”信号,在巨噬细胞中被TLR和Btk激活以进行分泌和细胞表面暴露,从而靶向癌细胞进行吞噬,即使癌细胞本身不表达钙网蛋白。